申请人:Tung Roger
公开号:US20090149399A1
公开(公告)日:2009-06-11
This invention relates to novel 2-6-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-2-methyl-pyrimidin-4-ylamino}-thiazole-5-carboxylic acid (2-chloro-6-methyl-phenyl)-amide derivatives, and pharmaceutically acceptable acid addition salts thereof. The invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions beneficially treated by the inhibition of kinases including Src-kinase and Bcr-Abl kinase.
这项发明涉及新颖的2-6-[4-(2-羟乙基)-哌嗪-1-基]-2-甲基-嘧啶-4-基氨基}-噻唑-5-羧酸(2-氯-6-甲基苯基)-酰胺衍生物,以及其药用可接受的酸盐。该发明还提供了包含本发明化合物的组合物,并且利用这些组合物在治疗通过抑制激酶(包括Src激酶和Bcr-Abl激酶)有益治疗的疾病和病况的方法。